NucleoSpin Dx Blood

Additional information

Brand

Applications

  • Isolation of genomic DNA from human whole blood samples for subsequent in‑vitro diagnostic purposes

Features

  • CE-IVD certification in compliance with EU directive 98/79/EC for in‑vitro diagnostic applications*
  • All purpose effectiveness compatible with all blood stabilization substances (e.g., citrate, EDTA, heparin)
  • Reproducible results for reliable downstream analysis

Specifications

  • Technology: Silica membrane technology
  • Sample material: Whole blood (200 μL)
  • Typical yield: 3–5 μg (depending on individual blood sample)
  • Elution volume: 50–200 μL
  • Processing time: 30 min/prep

* CE-IVD marked kit: not available in all countries, please inquire.